Here we used in vitro and in vivo mouse models of TSC to investigate whether manipulation of mTORC1 or mTORC2 signaling via genetic reduction of Raptor or Rictor, respectively, could ameliorate TSC-related brain phenotypes. This evidence concerns the gene RPTOR and tuberous sclerosis.